Benzodiazepines
Research News and Information

Monday, November 23, 2009

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

26 Oct 2009 CONTEXT: Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication. OBJECTIVE: To study the association of ... Read more...

[Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices]

3 Oct 2009 INTRODUCTION: The consumption of benzodiazepines (BZ) and cyclopyrrolones (CP) has attracted great interest in recent years due to the serious side-effects associated with these drugs. Two medical practices introduced a more restrictive approach to ... Read more...

Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.

29 Sep 2009 BACKGROUND: The European DRUID (Driving under the Influence of Drugs, Alcohol And Medicines) project calls for analysis of oral fluid (OF) samples, collected randomly and anonymously at the roadside from drivers in Denmark throughout 2008-2009. To ... Read more...

Latest indexed articles for 'Benzodiazepines'

These are the very latest articles for this heading:

• Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. 26 Oct 2009
• Seizures in a 9 month old girl. 19 Oct 2009
• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS. 29 Sep 2009
• Clinical trials design lessons from the CATIE study. 29 Sep 2009
• The association of olanzapine-induced weight gain with peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism in patients with schizophrenia. 29 Sep 2009
• Oral fluid testing for drugs of abuse. 8 Sep 2009
• Multisite solid catalyst for cascade reactions: the direct synthesis of benzodiazepines from nitro compounds. 5 Sep 2009
• [Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists] 30 Aug 2009
• The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic study. 30 Aug 2009
• Fatal pulmonary embolism following antipsychotic treatment and physical restraint. 30 Aug 2009
• Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. 30 Aug 2009
• Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data. 30 Aug 2009
• Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study. 30 Aug 2009
• FDA panel OKs 3 antipsychotic drugs for pediatric use, cautions against overuse. 24 Aug 2009
• The impact of diazepam's discovery on the treatment and understanding of status epilepticus. 6 Aug 2009
• [Influence of serotonin (5-HT) 2A-receptor and transporter (5HTT) gene polymorphism upon the effect of olanzapine] 30 Jul 2009
• Longer-term treatment of patients with bipolar disorder: a 9-month observational study in Central and Eastern Europe, the Middle East and Africa. 30 Jul 2009
• Development of a stability-indicating HPLC method for simultaneous determination of olanzapine and fluoxetine in combined dosage forms. 30 Jul 2009
• Intramuscular haloperidol versus intramuscular olanzapine for treatment of acute agitation: a cost-minimization study. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Benzodiazepines'

Definition: A group of two-ring heterocyclic compounds consisting of a benzene ring fused to a diazepine ring.

Registry Number: 12794-10-4

Descriptor UI: D001569

Alternative terms: Benzodiazepines; Benzodiazepine Compounds; Benzodiazepine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.438.079.080;

History Note: 75

Technical Notes: do not confuse with BENZODIAZEPINONES